Feb 24, 2021 7:01 am EST NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter
Feb 16, 2021 7:00 am EST NeoGenomics to Participate in the BTIG Virtual Medtech, Digital Health, Life Science & Diagnostic Tools Conference
Feb 5, 2021 7:00 am EST NeoGenomics Schedules its Fourth Quarter and Full Year 2020 Earnings Release for February 24, 2021
Feb 4, 2021 7:00 am EST Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials
Feb 2, 2021 7:58 am EST NeoGenomics and Tempus Join the Access to Comprehensive Genomic Profiling Coalition
Jan 6, 2021 11:00 pm EST NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
Jan 5, 2021 4:05 pm EST NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes
Jan 4, 2021 7:30 am EST NeoGenomics To Virtually Participate In The 39th Annual J.P. Morgan Healthcare Conference
Nov 13, 2020 4:05 pm EST NeoGenomics To Virtually Participate In Fireside Chat At The Stephens Annual Investment Conference 2020
